"Pressoreceptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.
Descriptor ID |
D011311
|
MeSH Number(s) |
A08.675.650.915.750.750 A08.800.050.800.900.700 A08.800.950.750.750 A11.671.650.915.750.750
|
Concept/Terms |
Pressoreceptors- Pressoreceptors
- Pressoreceptor
- Stretch Receptors, Vascular
- Receptor, Vascular Stretch
- Receptors, Vascular Stretch
- Stretch Receptor, Vascular
- Vascular Stretch Receptor
- Vascular Stretch Receptors
- Stretch Receptors, Arterial
- Arterial Stretch Receptor
- Arterial Stretch Receptors
- Receptor, Arterial Stretch
- Receptors, Arterial Stretch
- Stretch Receptor, Arterial
- Receptors, Stretch, Vascular
- Baroreceptors
- Baroreceptor
- Receptors, Stretch, Arterial
|
Below are MeSH descriptors whose meaning is more general than "Pressoreceptors".
Below are MeSH descriptors whose meaning is more specific than "Pressoreceptors".
This graph shows the total number of publications written about "Pressoreceptors" by people in this website by year, and whether "Pressoreceptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2021 | 1 | 0 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pressoreceptors" by people in Profiles.
-
Cardiac afferent signals can facilitate visual dominance in binocular rivalry. Elife. 2024 Oct 02; 13.
-
Novel Therapies on the Horizon of Hypertension Management. Am J Hypertens. 2023 02 13; 36(2):73-81.
-
A randomized placebo-control trial of the acute effects of oxygen supplementation on exercise hemodynamics, autonomic modulation, and brain oxygenation in patients with pulmonary hypertension. Respir Physiol Neurobiol. 2021 08; 290:103677.
-
Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up. Hypertension. 2017 May; 69(5):836-843.
-
Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure. Hypertension. 2015 Jan; 65(1):5-15.
-
Proceedings from Duke resistant hypertension think tank. Am Heart J. 2014 Jun; 167(6):775-88.e1.
-
Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches. J Clin Hypertens (Greenwich). 2014 Feb; 16(2):141-8.
-
The future of interventional management of hypertension: threats and opportunities. Curr Vasc Pharmacol. 2014 Jan; 12(1):69-76.
-
Sympathetic activation in resistant hypertension: theory and therapy. Semin Nephrol. 2014; 34(5):550-9.
-
Efficacy of baroreflex activation therapy for the treatment of resistant hypertension. EuroIntervention. 2013 May; 9 Suppl R:R136-9.